We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLTH
13701
PUT
DELISTED
Cue Health Inc. Common Stock
HLTH
$1.66K ﹤0.01%
10,200
+9,800
+2,450% +$3.25K
DMRA
13702
CALL
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.85B
$1.66K ﹤0.01%
+92
New +$1.42K
DTIL icon
13703
CALL
Precision BioSciences
DTIL
$188M
$1.64K ﹤0.01%
150
-47
-24% -$507
BBCP icon
13704
CALL
Concrete Pumping Holdings
BBCP
$497M
$1.64K ﹤0.01%
+200
New +$1.56K
MSAIW icon
13705
MultiSensor AI Holdings Warrant
MSAIW
$817K
$1.64K ﹤0.01%
+35,629
New +$1.4K
WKSP icon
13706
PUT
Worksport
WKSP
$11.1M
$1.64K ﹤0.01%
110
-210
-66% -$3.33K
KRRO icon
13707
CALL
Korro Bio
KRRO
$164M
$1.63K ﹤0.01%
34
-14
-29% -$461
BNZIW icon
13708
Banzai International Warrant
BNZIW
$167K
$1.63K ﹤0.01%
38,776
+20,863
+116% +$1.02K
CRDF icon
13709
PUT
Cardiff Oncology
CRDF
$72.3M
$1.63K ﹤0.01%
1,100
-7,400
-87% -$8.95K
GNSS icon
13710
PUT
Genasys
GNSS
$79.2M
$1.62K ﹤0.01%
800
-300
-27% -$532
PASG icon
13711
CALL
Passage Bio
PASG
$14.9M
$1.62K ﹤0.01%
80
-250
-76% -$3.45K
GRBK icon
13712
Green Brick Partners
GRBK
$3.1B
$1.61K ﹤0.01%
31
-123,509
-100% -$5.62M
AXDX
13713
PUT
DELISTED
Accelerate Diagnostics
AXDX
$1.57K ﹤0.01%
+400
New +$2.12K
DPCSW
13714
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
$1.56K ﹤0.01%
77,916
-1,629
-2% -$33
TCOA.WS
13715
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$1.56K ﹤0.01%
39,207
-122
-0.3% -$8
CLLS
13716
CALL
Cellectis
CLLS
$279M
$1.54K ﹤0.01%
500
-2,500
-83% -$5.93K
BPTH
13717
CALL
DELISTED
Bio-Path Holdings Inc
BPTH
$1.53K ﹤0.01%
+165
New +$1.74K
LAW icon
13718
PUT
CS Disco
LAW
$267M
$1.52K ﹤0.01%
200
-10,500
-98% -$66.2K
SLGC
13719
CALL
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.52K ﹤0.01%
600
-51,000
-99% -$119K
MCRB icon
13720
Seres Therapeutics
MCRB
$50.8M
$1.52K ﹤0.01%
54
-9,340
-99% -$245K
DNUT icon
13721
Krispy Kreme
DNUT
$531M
$1.51K ﹤0.01%
100
-52,528
-100% -$695K
BLUA.WS
13722
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$1.5K ﹤0.01%
37,881
-200
-0.5% -$7
CSTE icon
13723
CALL
Caesarstone
CSTE
$79.9M
$1.5K ﹤0.01%
400
-300
-43% -$1.21K
IRAAW
13724
DELISTED
Iris Acquisition Corp Warrant
IRAAW
$1.49K ﹤0.01%
49,449
-300
-0.6% -$10
TRX icon
13725
PUT
TRX Gold Corp
TRX
$267M
$1.48K ﹤0.01%
3,900
+900
+30% +$355

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.